Financials OpGen, Inc.

Equities

OPGN

US68373L4068

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.5149 USD -3.21% Intraday chart for OpGen, Inc. -18.27% +22.60%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 10.54 11.24 3.924 45.88 38.95 7.571
Enterprise Value (EV) 1 9.99 8.562 4.376 55.36 28.05 14.95
P/E ratio - -0.58 x -0.15 x -1.23 x -0.87 x -0.18 x
Yield - - - - - -
Capitalization / Revenue 3.28 x 3.81 x 1.12 x 10.9 x 9.05 x 2.9 x
EV / Revenue 3.11 x 2.91 x 1.25 x 13.1 x 6.51 x 5.74 x
EV / EBITDA -0.68 x -0.69 x -0.44 x -2.89 x -1.38 x -0.73 x
EV / FCF -1.13 x -1.32 x -0.48 x -5.46 x -1.7 x -0.99 x
FCF Yield -88.4% -76% -207% -18.3% -58.9% -102%
Price to Book - 3.4 x 1.47 x 2.41 x 1.13 x 1.08 x
Nbr of stocks (in thousands) 5.64 21.6 174 1,124 1,948 2,685
Reference price 2 1,868 520.0 22.60 40.80 20.00 2.820
Announcement Date 3/29/18 2/27/19 3/24/20 3/29/21 3/30/22 3/30/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 3.211 2.946 3.499 4.214 4.306 2.607
EBITDA 1 -14.6 -12.45 -10.05 -19.16 -20.39 -20.58
EBIT 1 -15.27 -13.18 -10.97 -21.49 -23.1 -22.22
Operating Margin -475.42% -447.35% -313.59% -510.02% -536.51% -852.18%
Earnings before Tax (EBT) 1 -15.42 -13.37 -12.45 -26.08 -34.76 -37.28
Net income 1 -15.42 -13.37 -12.45 -26.21 -34.81 -37.28
Net margin -480.2% -453.72% -355.75% -621.93% -808.3% -1,429.96%
EPS - -889.8 -154.0 -33.18 -22.89 -15.27
Free Cash Flow 1 -8.828 -6.508 -9.075 -10.13 -16.51 -15.18
FCF margin -274.92% -220.9% -259.39% -240.43% -383.46% -582.23%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/18 2/27/19 3/24/20 3/29/21 3/30/22 3/30/23
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 0.8116 1.239 1.426 0.4698 0.9672 0.4487 0.7216 0.9134 0.7361 0.699
EBITDA - - - - - - - - - -
EBIT 1 -6.023 -5.087 -5.919 -5.846 -5.272 -13.51 -9.935 -5.07 -5.156 -3.566
Operating Margin -742.13% -410.5% -415.21% -1,244.44% -545.09% -3,011.59% -1,376.81% -555.06% -700.46% -510.09%
Earnings before Tax (EBT) 1 -7.087 -6.057 -6.862 -6.804 -5.84 -14.1 -10.53 - -5.827 -4.063
Net income 1 -7.087 -6.057 -14.07 -6.804 -5.84 -14.1 -10.53 - -5.827 -4.063
Net margin -873.14% -488.79% -987.15% -1,448.37% -603.84% -3,143.23% -1,459.85% - -791.6% -581.24%
EPS 2 -3.800 -3.200 -7.000 -3.000 -2.600 -6.000 -3.870 - -0.9300 -0.4600
Dividend per Share - - - - - - - - - -
Announcement Date 8/12/21 11/11/21 3/29/22 5/12/22 8/11/22 11/10/22 3/29/23 5/15/23 8/10/23 11/14/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - 0.45 9.49 - 7.38
Net Cash position 1 0.55 2.68 - - 10.9 -
Leverage (Debt/EBITDA) - - -0.045 x -0.4952 x - -0.3588 x
Free Cash Flow 1 -8.83 -6.51 -9.08 -10.1 -16.5 -15.2
ROE (net income / shareholders' equity) -675% -568% -327% -206% -112% -153%
ROA (Net income/ Total Assets) -122% -106% -70.8% -44.7% -23.8% -28.5%
Assets 1 12.61 12.63 17.58 58.7 146.3 130.9
Book Value Per Share - 153.0 15.40 16.90 17.70 2.610
Cash Flow per Share - 212.0 9.700 10.70 15.50 2.570
Capex 1 0.28 0.15 0.03 0.13 1.98 0.59
Capex / Sales 8.63% 5.02% 0.91% 3.09% 46.07% 22.66%
Announcement Date 3/29/18 2/27/19 3/24/20 3/29/21 3/30/22 3/30/23
1USD in Million
Estimates
  1. Stock Market
  2. Equities
  3. OPGN Stock
  4. Financials OpGen, Inc.